In the wake of the COVID-19 pandemic, the debate surrounding vaccination for children has been a focal point for parents, healthcare professionals, and policymakers alike. Recent evidence now strongly ...

Research led by the University of Washington reports on an AI-guided method that designs epitope-specific antibodies and ...

It's time for us to reconnect with the radical, system-changing spirit that was once at the heart of our field.

PEMGARDA® (pemivibart) net product revenue of $13.1 million reported for Q3 2025, representing 41% growth year-over-year and 11% growth ...

A highly infectious variant of COVID-19 that has spread around the world since it was first discovered in Britain late last ...

Drugmaker Bristol-Myers Squibb Co (BMY.N) will globally develop, make and sell a therapy being tested by New York's ...

In a joint project, the two University of Cologne scientists are investigating mutations of viral pathogens in connection with the immune response / The European Research Council awards ERC Synergy Gr ...

Children whose mothers had COVID-19 during pregnancy appear to have an increased likelihood of being diagnosed with developmental conditions by age three, including speech delays and autism. This new ...

SARS-CoV-2 infections have been rising in the past month — global cases increased by more than 19,000 last month compared ...

When COVID-19 arrived, researchers tried to build evolutionary family trees—known as phylogenetic trees—of the virus. These ...

For patients with certain types of advanced lung or skin cancer, administration of SARS-CoV-2 mRNA vaccine within 100 days of starting ICIs is associated with increased overall survival.

First published in 1869, Nature is the world's leading multidisciplinary science journal. Nature publishes the finest ...